Form 4 for VKTX Viking Therapeutics, Inc.
Accepted 2026-03-10 00:00:00 ET · period of report 2026-03-10 · accession 0001193125-26-100581 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-03-10 | 2026-03-10 | VKTX | Aubuchon Neil William | Chief Commercial Off | P - Purchase | $33.50 | +4,475 | 4,475 | New | +$149.9K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock, par value $0.00001 per share | 2026-03-10 | P | A | 4,475 | $33.50 | 4,475 | D | — | — |